Chugai Pharmaceutical Co., Ltd.
June 23, 2026
Theater 2
Type: Company Presentation
Focus Area:
Multiple Therapeutics
Chugai Pharmaceutical Co., Ltd. is a Japan‑based research‑driven pharmaceutical company and a member of the Roche Group. Chugai is committed to creating innovative medicines that address unmet medical needs by leveraging its strong capabilities across multiple modalities, including antibody engineering, macrocyclic peptide and small molecule drug discovery, as well as translational science. The company has a broad research and development portfolio spanning multiple therapeutic areas, including oncology, immunology, neuroscience, hematology, and ophthalmology. Chugai advances science‑based innovation with a strong focus on patient‑centric value creation.
Company HQ City:
Tokyo
Company HQ State:
Tokyo
Company HQ Country:
Japan
Year Founded:
1925
Lead Product in Development:
Lead products in development include in‑house oncology programs, as well as selected programs in other therapeutic areas such as immunology.
CEO
Osamu Okuda, PhD
Development Phase of Lead Product
Multiple Products in Market
Exchange
TSE
Ticker
4519
When you expect your next catalyst update?
Depends on the project
What is your next catalyst (value inflection) update?
Upcoming value inflection points include clinical data readouts and development progress across our in-house programs.
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}